| Identification | Back Directory | [Name]
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester | [CAS]
2730022-56-5 | [Synonyms]
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester | [Molecular Formula]
C22H19N3O3 | [MOL File]
2730022-56-5.mol | [Molecular Weight]
373.4 |
| Hazard Information | Back Directory | [Uses]
HSD17B13-IN-38 (Compound D) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). HSD17B13-IN-38 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH[1]. | [References]
[1] Vincent FLORIO, et al. Substrate selective hsd17b13 inhibitors and uses thereof. WIPO, WO2021211981A1. 2021-10-21. |
|
|